Statistics for TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
Total visits
| views | |
|---|---|
| TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT | 11 |
Total visits per month
| views | |
|---|---|
| November 2024 | 1 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| TRIB2 confers resistance to anti-cancer therapy by activating the serine threonine protein kinase AKT.pdf | 11 |
Top country views
| views | |
|---|---|
| Turkey | 10 |
| United States | 1 |
Top city views
| views | |
|---|---|
| Sincan | 10 |
| Boardman | 1 |